JP Morgan Maintains Overweight on HeartFlow, Lowers Price Target to $35

Benzinga Newsdesk www.benzinga.com Negative 86.3%

Neg 86.3% Neu 0% Pos 0%

JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and lowers the price target from $40 to $35.